Successful switch to tenofovir after suboptimal response to entecavir in an immunocompromised patient with chronic hepatitis B and without genotypic hepatitis B virus resistance

C. Sarrecchia, V. Svicher, A. Volpi, R. Salpini, L. Ceccarelli, P. Sordillo, A. Bertoli, C. F. Perno, M. Andreoni

Research output: Contribution to journalArticle


We report a case of an immunocompromised patient affected by chronic hepatitis B virus (HBV) with high basal HBV viremia (>8 log 10 IU/ml) who failed an entecavir regimen, despite the absence of primary or secondary drug resistance mutations. The patient achieved sustained virological success (serum HBV DNA

Original languageEnglish
Pages (from-to)367-370
Number of pages4
Issue number4
Publication statusPublished - Aug 2011



  • Drug resistance
  • Entecavir
  • Hepatitis B
  • Immunocompromised
  • Therapy

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this